Long-term survivors in metastatic lung cancer study
Part of Cancer, Lungs & breathing clinical trials.
This study looks at people who have lived more than three years with advanced lung cancer (non-small cell or small cell) that has spread. The goal is to better understand why some people do well for a long time and how to help more patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have been living with stage IV or stage III non-small cell or small cell lung cancer for more than three years
- You are not currently receiving chemotherapy (you may be on immunotherapy, targeted therapy, or just being watched)
- You are covered by the French National Health Insurance or private health insurance
- You can understand and answer questions in French
- You are able to give permission to collect your data
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people with hard-to-treat cancers live much longer than expected. It collects tumor samples to search for clues that might help future patients.
This study collects medical information and test results from people with lung cancer that has spread (or cannot be cured with local treatment). It does not test a new drug; it helps researchers better understand patients’ health and care needs over time.
This study follows patients over time to see how anticancer treatments affect their quality of life. It's for adults who receive special cancer drugs and also get other support at the Rafael Institute.
This trial tests whether using a web-based tool to track symptoms can help people with advanced lung cancer live longer and feel better. You would report symptoms regularly, and your care team would use that information to adjust your care.
This study looks at patients with advanced non-small cell lung cancer who received immunotherapy (immune checkpoint inhibitors) alone or in combination with other treatments. It aims to understand why some patients survive longer than others by analyzing their medical data and using AI to predict outcomes.
This study looks at how lung cancer and its treatment might affect thinking and memory. If you are having surgery for early-stage lung cancer, you may be asked to complete online questionnaires to help researchers track these changes over time.
Hear when a new Metastatic Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.